2nd Cancer Epigenetics
08 Nov 2012 - 09 Nov 2012 - Boston, MA, USA
GTC’s 2nd Cancer Epigenetics Conference, one of two parallel tracks of the Cancer Summit - Novel Approaches to Drug Discovery on November 8-9 in Boston, MA, is the only cancer epigenetics conference that brings together leading experts from the industry and academia to collaborate on the latest cutting edge research on novel mechanisms, therapeutics, drug discovery, developments, biomarkers and diagnostics for cancer epigenetics. This meeting will be one of the first occasions where recent high profile disclosures made in the likes Nature and Cell will be discussed. Experts in the field will discuss how epigenetic diagnostic technologies have great potential for enabling a new age of targeted or personalized cancer therapies. The Biomarker and Diagnostics session features molecular discoveries from speakers on Epigenetic Readers, Drug Discovery, Preclinical and Clinical Assets which can help deliver drugs accurately targeted for efficacy and well characterized for selectivity and safety.